GlassScriptPhysician profile
Sandesh Dewan
NPI 1013564152
$598.14
in general payments reported to CMS, 2019-2025
12 companies · $529 in 2025
The $529 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $17.81 · 2024: $51.17 · 2025: $529.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $598.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $598.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $162.58 | 2024-2025 | Evenity, Tepezza, Prolia |
| Novo Nordisk INC | $80.70 | 2025 | Wegovy, Ozempic, Rybelsus |
| Abbott Laboratories | $57.73 | 2025 | Freestyle Libre 3 |
| Recordati_rare_diseases_inc. | $51.74 | 2025 | Isturisa |
| Tandem Diabetes Care, INC. | $48.10 | 2024-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Lilly USA, LLC | $36.93 | 2025 | Jardiance, Mounjaro |
| Acella Pharmaceuticals, LLC | $36.74 | 2024-2025 | NP Thyroid 60 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.82 | 2025 | Jardiance |
| Medtronic, INC. | $34.56 | 2023-2025 | Minimed 780g |
| Rgh Enterprises LLC | $22.28 | 2025 | |
| Dexcom, INC. | $18.25 | 2025 | Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $13.71 | 2025 | Shingrix, Arexvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandesh Dewan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.